SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-000767
Filing Date
2020-01-10
Accepted
2020-01-10 16:30:35
Documents
5
Period of Report
2020-01-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prnb-8k_20200107.htm 8-K 36455
2 EX-99.1 prnb-ex991_6.htm EX-99.1 16752
3 EX-99.2 prnb-ex992_7.htm EX-99.2 36650
4 GRAPHIC g32d2gfu1nga000001.jpg GRAPHIC 4729
5 GRAPHIC gnjq4addgdnp000001.jpg GRAPHIC 4729
  Complete submission text file 0001564590-20-000767.txt   104305
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38653 | Film No.: 20521382
SIC: 2834 Pharmaceutical Preparations